amarantac retweeted
Replying to @dr_cellini
I wrote a whole paper in it. More a specialty is dishonest about their operating time the more RVUs they get.
pubmed.ncbi.nlm.nih.gov/3423…
The best of the rest! Come for the La Croix, stay for the talks. Palliative care in our gyn onc population. So proud of M. Fatima Reyes @BIDMC_ObGyn @UCSF_ObGynRS @UCSF_LCOE @UCSFHospitals @SGO_org #sgo2023 #SGOMtg
This talk also titled “Brown faces in amazing places” (from the OG @OliviaCampaMD)
amarantac retweeted
Studies have found that acquisitions by private-equity firms have led to consolidation and increases in hospital charges and net income. Jaime King, JD, PhD, explains what this means for patients and the health care industry. Listen to the full interview: nej.md/408KmW2
What a fascinating study by @sarahleemdmba on disaggregating AAPI in NCDB #sgo2023 #SGOMtg @SGO_org @nyulangone 1/4 patients couldn’t be disaggregated. Wish we could replicate in a robust database for the melting pot of Latinos
amarantac retweeted
Striking data presented by @dholakiamd - Fellows and early career Gyn Onc faculty are unprepared for productivity negotiation. @MLiangMD @EmelineAvikiMD #sgo2023 #SGOMtg #PatientsPurposeProgress
Also so so practice changing in the late breaking abstracts @SGO_org #sgo2023 #SGOMtg #lookatthoseHR
#SGOMtg: A randomized trial compared standard chemotherapy plus dostarlimab or placebo. Patients with mismatch repair–deficient tumors had 2-year progression-free survival of 61.4% with dostarlimab and 15.7% with placebo. Read full results of RUBY trial: nej.md/40lFbBN
Late breaking at #SGOMtg: In patients with advanced or recurrent endometrial cancer, the addition of pembrolizumab to standard chemotherapy resulted in significantly longer progression-free survival than chemotherapy alone. nej.md/3FJ4J3R
amarantac retweeted
🧵regarding the 'suture ligature' or 'stick tie', or whatever you call it in your part of the world.
Here, I'll use my long-suffering chickens to show 3 different methods for doing a 'suture ligature', and we'll go over a couple of pointers that apply to all of them.
(1/ )
amarantac retweeted
Just a couple of #sgobridges scholars enjoying #sgo2023! Thank you @amandanfader and Dr. Sarah Adams for developing the SGO BRIDGES initiative. Can’t wait for the year to come! @SGO_org #SGOMtg
amarantac retweeted
Dr Horowitz presenting important data from GOG 279 on the role of #gemcitabine in vulvar SCC. Interesting use of radiosensitizing characteristics of #gemcitabine in a disease traditionally treated with a disfiguring and functionally debilitating dz. #SGOMtg #sgo2023
amarantac retweeted
Many times the needles come packaged so that it facilitates picking them up right at one of the two classic locations we just mentioned:
-the midpoint (red arrow)
-or about 2/3 back (blue arrow)
amarantac retweeted
SGO celebrates the inaugural launch of the BRIDGES Research Initiative with a kick-off in Orlando today! We are excited to share more about this program and the selected cohort soon. ow.ly/AlFq50MAiIo
Go MGJ!!! 🥳 🎉 👏👏👏👏
Its been a long journey for this #firstgen #Mexican immigrant, and I am a little late in celebrating, but happy to say I am a board certified #medical #oncologist 🙌🏼 Thank you to study partners, mentors, and my family for the support! @LatinxOncology @LatinasInMed
amarantac retweeted
Navy seal: "Training did not select for the strongest and fastest… instead those that in their worst moments found it within themselves to help a fellow seal."
That statement made me think about medical training…
what types does it select for? And is it the right types?
amarantac retweeted
For medical students applying to [ob/gyn] residency, here is a guide on navigating interviews in states with abortion restrictions ryanprogram.org/cms/assets/u… Thanks to @UCSFBixby Ryan Program @LmsaNational #LatinxinObgyn #AbortionIsHealthcare


































